Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

386
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
386
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

491
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
491
Teratogenicity01:07

Teratogenicity

4.6K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.6K
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

39
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
39
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

3.3K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.3K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

2.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

There's an app for that: promoting independence in child and adolescent health.

Current opinion in pediatrics·2026
Same author

Clinical concerns and considerations for leucovorin use in autism spectrum disorder.

Current opinion in pediatrics·2026
Same author

Navigating nature's remedies: herbal and botanically derived complementary alternative medicine for children.

Current opinion in pediatrics·2025
Same author

The potential of artificial intelligence to transform medicine.

Current opinion in pediatrics·2025
Same author

What Premedical Students Need to Succeed: Updated Premed Competencies for Entering Medical Students.

Academic medicine : journal of the Association of American Medical Colleges·2025
Same author

Artificial intelligence impacts in education and pediatric mental health.

Current opinion in pediatrics·2025
Same journal

Childhood sleep disorders: practical management for the pediatrician.

Current opinion in pediatrics·2026
Same journal

Advanced therapies in management of pediatric inflammatory bowel disease.

Current opinion in pediatrics·2026
Same journal

Artificial intelligence in pediatric endoscopy for hereditary polyposis syndromes: promises and challenges.

Current opinion in pediatrics·2026
Same journal

Hormonal acne therapies in pediatrics.

Current opinion in pediatrics·2026
Same journal

Clinical implementation of artificial intelligence in adolescent mental healthcare.

Current opinion in pediatrics·2026
Same journal

Advances in the treatment of pediatric hidradenitis suppurativa: emerging therapies and future directions.

Current opinion in pediatrics·2026
See all related articles

Related Experiment Video

Updated: Apr 9, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

12.0K

Macro preemies: no thresholds for risks or concerns.

Laura Fletcher1, Ruth Milanaik

  • 1Developmental & Behavioral Pediatrics, Steven & Alexandra Cohen Children's Medical Center of New York, New Hyde Park, New York, USA.

Current Opinion in Pediatrics
|June 19, 2015
PubMed
Summary
This summary is machine-generated.

Moderate to late preterm infants (32-36 weeks gestation) face significant medical and developmental risks. Early and comprehensive follow-up care is crucial for these infants, often called "macro preemies," to mitigate potential health issues.

More Related Videos

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

88.5K
A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis
06:19

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis

Published on: January 7, 2018

11.0K

Related Experiment Videos

Last Updated: Apr 9, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

12.0K
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

88.5K
A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis
06:19

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis

Published on: January 7, 2018

11.0K

Area of Science:

  • Neonatal Medicine
  • Developmental Pediatrics

Background:

  • Moderate to late preterm infants (32-36 weeks gestation) are at increased risk for medical and developmental issues.
  • These infants, sometimes termed 'macro preemies,' experience morbidities due to immature organ systems.

Purpose of the Study:

  • To review the literature on medical and developmental risks for moderate to late preterm infants.
  • To highlight the pediatrician's role in managing these infants during inpatient and outpatient care.

Main Methods:

  • Literature review of medical and developmental risks.
  • Focus on care strategies for preterm infants.

Main Results:

  • Infants born at 32-36 weeks gestation show higher risks for medical complications (e.g., temperature instability, respiratory issues, feeding difficulties, jaundice, hypoglycemia, infections).
  • These infants also exhibit increased incidence of developmental deficits in motor skills, speech, communication, learning, and behavior compared to full-term infants.
  • Careful attention from birth is necessary to address potential medical and developmental delays.

Conclusions:

  • Physicians must recognize the heightened medical and developmental risks in preterm infants.
  • Comprehensive medical and neurodevelopmental follow-up care is essential for all infants born before term.